Umhlahlandlela Weziguli Ezinsini Ze-Canal Cell Skin Cancer, Izimpawu Nezokwelapha
I-basal cell carcinoma iyindlela ejwayelekile kunazo zonke zomdlavuza emhlabeni wonke, kubalwa cishe ngamaphesenti angu-80 kuwo wonke amacala omdlavuza wesikhumba . Uma wena noma othandekayo usanda kutholakala ukuthi une-basal cell carcinoma, lokhu kuhlolisisa kuzokusiza ukuba uqonde lesi sifo futhi wenze ukhetho oluningi olunokwelashwa olunolwazi.
Isigameko
Abantu abangaphezu kwesigidi babhekwa ukuthi bane-basal cell carcinoma (BCC) unyaka ngamunye e-United States.
Kwake itholakala ikakhulu kubantu abadala noma asebekhulile kodwa manje ibonakala ngokuningi nangaphezulu eminyakeni encane. Isigameko se-BCC senyukile futhi manje sebizwa ngokuthi "isifo" abanye ochwepheshe.
Izingozi Zezingozi
Abantu baseCaucasus, ikakhulukazi labo abanamehlo aluhlaza okwesibhakabhaka, ubuciko obuhle, nezinwele ezibomvu, ezimhlophe noma ezibomvu (ubukhokho bamaCeltic), banomngcipheko omkhulu we-BCC. I-BCC inokwenzeka kodwa ayivamile kuma-Afrika-American, ama-Asia, nama-Hispanics. Uma kuqhathaniswa namaCaucasians, abantu base-Afrika-baseMelika banciphise ingozi ye-BCC ezindaweni ezivuliwe zelanga, kodwa isimo esifanayo se-BCC esikhumbeni esikhulelwe. Kukhona nezinye izinto eziningi eziyingozi.
Izimbangela
Ukwehliswa ngokweqile ekukhanyeni kwe-ultraviolet kusukela elangeni noma ukuthungulwa kwe-salon kubangela ama-80% wezehlakalo ze-BCC. Noma kunjalo, i-BCC ayihambisani nokukhanya kwelanga kunokuthi, isibonelo, i- squamous cell carcinoma , futhi ingenzeka ezindaweni ezingabonakali ilanga nhlobo, njenge-scalp. Abantu abahlala emazweni eduze ne-equator (njengeFlorida), noma ngomlando wokushisa kwelanga ngesikhathi sebuntwana, bangabona ifomu le-BCC lezilonda kuma-20s.
Ngokuvamile, isikhathi sokukhushulwa sithatha iminyaka engu-10 kuya kwengu-20.
Ukubukeka
I- basal cell lesion ivame ukuchazwa odokotela njenge- papule yamaparele - "i-pearly" okusho ukuthi inokukhanya okuncane, ngokungafani nezilonda ezinobuthi (ezingekho-umdlavuza) ezibomvu ne-scaly, ne-"papule" okusho ukuthi iphakanyisiwe ngaphezu kwendawo yesikhumba.
Imithwalo yegazi ehlanjululwayo ingawudlula esimweni esibizwa nge- telangiectasia . Lezi zithombe zesifo somdlavuza wesikhumba se-basal zibonisa ukuthi izilonda ze-BCC zingathatha izinhlobo ezihlukahlukene zokubonakala, ngakho-ke i-biopsy yindlela kuphela yokwenza ukuxilongwa okucacile.
Izinhlobo
- I-noodular : Mayelana no-60% we-BCCs i-nodular. Ziqala njengezilonda eziphambene, ezicacisiwe kahle, bese ziba yizintambo ezincane, ekugcineni ziwela phakathi, zishiye indandatho ephakanyisiwe emngceleni. I-nodular kakhulu ye-BCCs isebusweni futhi ingaba yinkimbinkimbi uma ingelashwa ngokushesha.
- I-pigmented : I-BCCs enama-pigmented afana nohlobo lwe-nodular, kodwa ingaba nezindawo ezimnyama noma ezimnyama, ezingabadibanisa ngezinhlobo ezithile ze-melanoma.
- I-Fibrosing noma i-Sclerotic : Lawa ma-BCC avame ukutholakala ebusweni futhi abukeke afana nezinhlamvu. Ngokuvamile ziqinile, zichazwe emngceleni, zihlala phansi noma zicindezelekile kancane, zimibalabala, futhi ubuso buvame ukuba bushelelezi futhi bukhazimule.
- Okuyisisekelo : Lolu hlobo luhlanganisa cishe ama-15% we-BCCs. Bendlala ngaphandle ebusweni obubomvu, echazwe kahle, e-scaly, esivame ukutholakala esiqu nasemlenzeni. Zidideka kalula nge-psoriasis noma i-eczema.
- I-Fibroepithelioma ye-Pinkus : Lona uhlobo olungavamile lwe-BCC. Kuvame ukuba yi- nodule encane ephakeme, ephakanyisiwe, encane etholakala ngasemuva, emaphethelweni, e-groin, noma enyangeni yonyawo. Njengoba lezo zingekho izindawo ezivezwa yelanga, lesi sifo cishe asihlobene nelanga.
Ukuxilongwa
I-biopsy yesikhumba ukukhipha izicubu zesikhumba zokuhlolwa ngaphansi kwe-microscope ngenhloso yokuxilongwa. Uhlobo oluqondile lwe-biopsy luxhomeke ekujuleni kwesilonda esikhunjeni:
- Shave biopsy isebenzisa umshini wokugcoba omncane ukugoba izingxenyana eziphezulu zesikhumba. Lena indlela ejwayelekile kakhulu yokuthola i-BCC.
- I-Punch biopsy isebenzisa ithuluzi elizungezayo, elikhukhi-lokusika. Isetshenziselwa ukuthatha isampula lesikhumba esijulile.
Ukwelapha
Ukwelashwa kuxhomeke kohlobo, ububanzi, nendawo ye-lesion. Nakuba i-BCC ingajwayelekile ekusakazeni ezithombeni ezikude (izidakamizwa), izilonda zingagcina zidala ukungasebenzi futhi kufanele zisuswe ngokushesha ngangokunokwenzeka.
Ukwelashwa okudingekayo ukuzisusa kulula kakhulu futhi kuncane kakhulu okubangela ukonakala okuphawulekayo uma kuncane. Izindlela ezivamile zokwelapha i-BCC zihlanganisa:
- Ukukhishwa kanye ne-electrodesiccation
- Ukucabangela okuhlinzekwayo (ukususwa)
- Ukuhlinzeka kwe-Mohs (eyaziwa nangokuthi "ukuhlinzekwa kwe-micrographic"), ikakhulu uma i-lesion isesimweni, iphindaphinda, inesisindo sobukhulu ngaphezu kwe-2 cm, noma uhlobo lwama-sclerotic
- Ama-cream e-topical ezifana ne- imiquimod yi-FDA-avunyelwe ukwelashwa kwe-BCCs engekho ebusweni, nakuba izifundo zibonise ukuthi zingasebenza ngokumelene ne-nodular BCC kanye
Uma i-basal cell carcinoma ishiywe ingaphathwa, izilonda zingakhula zibe ngamasentimitha amaningi bese zigcina zilonda (ziphule isikhumba) noma zilimaze izicubu noma amathambo azungezile. (Kukhona amacala abikwa ngabantu abalahlekelwa iso, impumulo noma indlebe ngenxa ye-BCC engasetshenzisiwe.) Ikakhulukazi uma kwenzeka ebusweni, ama-BCC kufanele asuswe masinyane ukuze avimbele ukungasebenzi ngenxa ye-lesion ngokwayo noma ukuhlinzwa. Ngeshwa, kungakhathaliseki ukuthi isuswe ngokushesha kangakanani, umuntu onomlando we-BCC unamathuba angama-40% amakhulu okuthuthukisa i-BCC yesibili kunomuntu ongenawo umlando.
I-Basal cell carcinoma iyona evame kakhulu - kepha futhi enye yezokwelapha kakhulu - zonke izinhlobo zegciwane. Sicela ubone udokotela wakho ngokushesha uma uthola izilonda ezingavamile ngesikhathi isikhumba sakho esijwayelekile sokuzihlola .
Imithombo:
"Iyini i-Basal Cell Carcinoma?" College College yaseNingizimu Carolina. 4 Septemba 2008.
"Umhlahlandlela oningiliziwe: I-Cancer Cancer - I-Basal and Cell Squamous" I-American Cancer Society. 5 Novemba 2008.
"I-Basal and Squamous Cell Cancer Cancer" I-National Comprehensive Cancer Network. 5 Novemba 2008.